Search Within


Applied Filters:
Showing 1-6 of 6 results for "SAB4502850" within Papers
Absence of sterol regulatory element-binding protein-1 (srebp-1) ameliorates fatty livers but not obesity or insulin resistance inlep ob/lep ob mice.
Yahagi N, et al.
The Journal of Biological Chemistry, 277(22), 19353-19357 (2002)
Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11. 2 and 22q13.
Hua X, et al.
Genomics, 25(3), 667-673 (1995)
The membrane anchor of the transcriptional activator SREBP is characterized by intrinsic conformational flexibility.
Linser R, et al.
Proceedings of the National Academy of Sciences of the USA, 112(40), 12390-12395 (2015)
Mathieu Schmitt et al.
Synapse (New York, N.Y.), 70(3), 71-86 (2015-12-24)
The identification of an effective disease-modifying treatment for the neurodegenerative progression in Parkinson's disease (PD) remains a major challenge. Epidemiological studies have reported that intake of statins, cholesterol lowering drugs, could be associated to a reduced risk of developing PD.
SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis.
Wang X, et al.
Cell, 77(1), 53-62 (1994)
Mathieu Schmitt et al.
Synapse (New York, N.Y.), 71(9) (2017-04-14)
The therapeutic use of statins has been associated to a reduced risk of Parkinson's disease (PD) and may hold neuroprotective potential by counteracting the degeneration of dopaminergic neurons. Transcriptional activation of the sterol regulatory element-binding protein (SREBP) is one of
Page 1 of 1